1. Withaferin A Increases the Effectiveness of Immune Checkpoint Blocker for the Treatment of Non-Small Cell Lung Cancer
   Roukiah Khalil et al, 2023, Cancers CrossRef
2. Plasma Proteome–Based Test for First-Line Treatment Selection in Metastatic Non–Small Cell Lung Cancer
   Petros Christopoulos et al, 2024, JCO Precision Oncology CrossRef
3. Artificial Intelligence and Machine Learning in Predicting the Response to Immunotherapy in Non-small Cell Lung Carcinoma: A Systematic Review
   Tanya Sinha et al, 2024, Cureus CrossRef
4. B cell‐dependent subtypes and treatment‐based immune correlates to survival in stage 3 and 4 lung adenocarcinomas
   Susan Raju Paul et al, 2023, FASEB BioAdvances CrossRef
5. BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer
   Clemence Demerlé et al, 2021, Frontiers in Oncology CrossRef
6. Immunological markers for predicting the response to immunotherapy in non-small cell lung cancer
   A. A. Musaelyan et al, 2022, Advances in Molecular Oncology CrossRef